The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care

被引:7
|
作者
Schreiner, Andrew D. [1 ]
Moran, William P. [1 ]
Zhang, Jingwen [1 ]
Livingston, Sherry [2 ]
Marsden, Justin [1 ]
Mauldin, Patrick D. [1 ]
Koch, David [1 ]
Gebregziabher, Mulugeta [2 ]
机构
[1] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA
关键词
FIB-4; NAFLD; Chronic liver disease; NONALCOHOLIC STEATOHEPATITIS; DISEASE; RISK; MANAGEMENT; FIB-4; STAGE; MORTALITY; AWARENESS; ICD-9-CM; PATHWAY;
D O I
10.1007/s11606-021-07341-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The Fibrosis-4 Index (FIB-4)non-invasively assesses fibrosis risk in chronic liver disease (CLD), but underdiagnosis limits FIB-4's application in primary care. Objective To evaluate the association of FIB-4 risk with hazard of severe liver outcomes in primary care patients with and without diagnosed CLD. Design Retrospective cohort study of primary care data from 2007 to 2018. Participants Adult patients with qualifying aminotransferase and platelet count results were included and a single FIB-4 score was calculated for each patient using the first of these values. Patients with a CLD diagnosis or outcome prior to their FIB-4 score were excluded. Measures FIB-4 advanced fibrosis risk categorization (low, indeterminate, and high) was the primary predictor variable. Patients were followed from FIB-4 score to a severe liver outcome, a composite of cirrhosis, liver transplantation, and hepatocellular carcinoma. We analyzed the association of FIB-4 risk categories with hazard risk of a severe liver outcome using stratified Cox regression models, stratifying patients by known CLD. Key Results A total of 20,556 patients were followed for a mean 2,978 days (SD 1,201 days), and 4% of patients experienced a severe liver outcome. Of patients with low-, indeterminate-, and high-risk FIB-4 scores, 2%, 4%, and 20% suffered a severe liver outcome, respectively. In the overall adjusted model, high-risk FIB-4 scores were associated with hazard of severe liver disease (HR 6.64; 95% CI 5.58-7.90). High-risk FIB-4 scores were associated with severe liver outcomes for patients with known NAFLD (HR 7.32; 95% CI 3.44-15.58), other liver disease (HR 11.39; 95% CI 8.53-15.20), and no known CLD (HR 4.05; 95% CI 3.10-5.28). Conclusions High-risk FIB-4 scores were strongly associated with risk of severe liver outcomes in patients with and without known CLD. Comprehensive FIB-4 application in primary care may signal silently advancing liver fibrosis.
引用
收藏
页码:3266 / 3274
页数:9
相关论文
共 50 条
  • [1] The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care
    Andrew D. Schreiner
    William P. Moran
    Jingwen Zhang
    Sherry Livingston
    Justin Marsden
    Patrick D. Mauldin
    David Koch
    Mulugeta Gebregziabher
    [J]. Journal of General Internal Medicine, 2022, 37 : 3266 - 3274
  • [2] THE FIBROSIS-4 INDEX AND SEVERE LIVER DISEASE OUTCOMES IN PRIMARY CARE: A STRATIFIED COX ANALYSIS
    Schreiner, Andrew D.
    Moran, William
    Zhang, Jingwen
    Mauldin, Patrick
    Livingston, Sherry
    Marsden, Justin
    Koch, David G.
    Gebregziabher, Mulugeta
    [J]. HEPATOLOGY, 2021, 74 : 125A - 125A
  • [3] IMPROVING THE CARE OF VETERANS WITH ELEVATED FIBROSIS-4 INDEX SCORES
    Garbarino, Stephanie
    Wall, April
    Burt, Michael
    Moylan, Cynthia A.
    [J]. HEPATOLOGY, 2022, 76 : S1048 - S1049
  • [4] Association of liver fibrosis-4 index with adverse outcomes in hypertrophic cardiomyopathy patients
    Abdu, Fuad A.
    Mareai, Redhwan M.
    Xiang, Lanqing
    Galip, Jassur.
    Mohammed, Abdul-Quddus
    Zhang, Wen
    Liu, Lu
    Wang, Chunyue
    Mohammed, Ayman A.
    Yin, Guoqing
    Lv, Xian
    Xu, Yawei
    Che, Wenliang
    [J]. ESC HEART FAILURE, 2024,
  • [5] Association between elevated fibrosis-4 index of liver fibrosis and risk of hemorrhagic stroke
    Parikh, Neal S.
    Zhang, Cenai
    Bruce, Samuel S.
    Murthy, Santosh B.
    Rosenblatt, Russell
    Liberman, Ava L.
    Liao, Vanessa
    Kaiser, Jed H.
    Navi, Babak B.
    Iadecola, Costantino
    Kamel, Hooman
    [J]. EUROPEAN STROKE JOURNAL, 2024,
  • [6] Nonalcoholic Fatty Liver Disease in Overweight Primary Care Patients: Comparison of Clinical Diagnosis vs Fibrosis-4 and Hepatic Steatosis Index Scores
    Wang, Hill
    Tessier, Katelyn
    De Groen, Piet C.
    Albrecht, Jeffrey H.
    Bramante, Carolyn
    Ikramuddin, Sayeed
    Dutta, Nirjhar
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S957 - S957
  • [7] Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease
    Ouzan, Denis
    Mosnier, Anne
    Penaranda, Guillaume
    Daviaud, Isabelle
    Joly, Helene
    Muntlak, Monelle
    Cohen, Jean Marie
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E986 - E991
  • [8] The Change in the Fibrosis-4 Index for the Assessment of Liver Fibrosis After Pancreaticoduodenectomy
    Tani, Masaji
    Maehira, Hiromitsu
    Iida, Hiroya
    Mori, Haruki
    Miyake, Toru
    Nitta, Nobuhito
    [J]. PANCREAS, 2022, 51 (06) : 624 - 627
  • [9] Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD
    Barbosa, Joana Vieira
    Milligan, Scott
    Frick, Andrew
    Broestl, Jeremy
    Younossi, Zobair
    Afdhal, Nezam H.
    Lai, Michelle
    [J]. HEPATOLOGY COMMUNICATIONS, 2022, 6 (04) : 765 - 779
  • [10] Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease
    Ouzan, Denis
    Mosnier, Anne
    Penaranda, Guillaume
    Daviaud, Isabelle
    Joly, Helene
    Muntlak, Monelle
    Cohen, Jean Marie
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E986 - E991